
VolitionRx Limited VNRX
€ 0.15
-3.83%
Geschäftsbericht 2025
hinzugefügt 31.03.2026
VolitionRx Limited Langfristiger Schuldenstrom 2011-2026 | VNRX
Langfristiger Schuldenstrom Jährlich VolitionRx Limited
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 250 K | 222 K | 199 K | 245 K | 171 K | 180 K | 257 K | - | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 257 K | 171 K | 218 K |
Langfristiger Schuldenstrom anderer Aktien in der Diagnostik & Forschung
| Name | Langfristiger Schuldenstrom | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
2.18 M | - | -6.23 % | $ 30.6 M | ||
|
Aspira Women's Health
AWH
|
202 K | - | -6.19 % | $ 10.5 M | ||
|
Biocept
BIOC
|
518 K | - | -13.05 % | $ 7.29 M | ||
|
BioNano Genomics
BNGO
|
697 K | $ 1.13 | -2.59 % | $ 6.15 M | ||
|
Chembio Diagnostics
CEMI
|
915 K | - | 0.22 % | $ 16.8 M | ||
|
DermTech
DMTK
|
3.07 M | - | -11.32 % | $ 2.94 M | ||
|
CareDx, Inc
CDNA
|
6.52 M | $ 16.05 | -3.83 % | $ 855 M | ||
|
Akumin
AKU
|
17.2 M | - | -17.87 % | $ 25.9 M | ||
|
Enzo Biochem
ENZ
|
841 K | - | -8.98 % | $ 14.8 K | ||
|
Interpace Biosciences
IDXG
|
431 K | $ 2.3 | - | $ 10.2 M | ||
|
Exact Sciences Corporation
EXAS
|
33.6 M | - | - | $ 19.8 B | ||
|
Co-Diagnostics
CODX
|
662 K | $ 4.4 | 101.83 % | $ 5.85 M | ||
|
Accelerate Diagnostics
AXDX
|
829 K | - | -61.36 % | $ 2.46 M | ||
|
Castle Biosciences
CSTL
|
1.66 M | $ 23.13 | -1.28 % | $ 642 M | ||
|
Global Cord Blood Corporation
CO
|
147 K | - | - | $ 399 M | ||
|
Genetic Technologies Limited
GENE
|
264 K | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
21.5 M | - | 0.12 % | $ 80.1 M | ||
|
Charles River Laboratories International
CRL
|
57.7 M | $ 175.65 | 0.06 % | $ 8.71 B | ||
|
Medpace Holdings
MEDP
|
23.2 M | $ 493.53 | -1.59 % | $ 14.2 B | ||
|
Danaher Corporation
DHR
|
199 M | $ 189.61 | -1.7 % | $ 135 B | ||
|
Heska Corporation
HSKA
|
2.94 M | - | - | $ 1.31 B | ||
|
HTG Molecular Diagnostics
HTGM
|
475 K | - | -20.0 % | $ 1.06 M | ||
|
Illumina
ILMN
|
79 M | $ 120.93 | -2.22 % | $ 19.2 B | ||
|
Myriad Genetics
MYGN
|
6.9 M | $ 4.35 | -2.03 % | $ 403 M | ||
|
Fulgent Genetics
FLGT
|
1.44 M | $ 14.43 | -3.93 % | $ 436 M | ||
|
NeoGenomics
NEO
|
4.78 M | $ 7.69 | -3.17 % | $ 985 M | ||
|
Guardant Health
GH
|
27.7 M | $ 78.6 | -9.83 % | $ 9.85 B | ||
|
QIAGEN N.V.
QGEN
|
23.4 M | - | - | $ 10.6 B | ||
|
Anixa Biosciences
ANIX
|
41 K | $ 2.69 | -1.82 % | $ 87.3 K | ||
|
Biomerica
BMRA
|
358 K | $ 2.13 | -0.9 % | $ 4.89 M | ||
|
Koninklijke Philips N.V.
PHG
|
241 M | $ 28.31 | 0.62 % | $ 20 B | ||
|
ICON Public Limited Company
ICLR
|
24.3 M | $ 106.81 | 0.1 % | $ 8.81 B | ||
|
Check-Cap Ltd.
CHEK
|
264 K | - | - | $ 9.42 M | ||
|
Laboratory Corporation of America Holdings
LH
|
191 M | $ 260.93 | -4.51 % | $ 21.7 B | ||
|
Natera
NTRA
|
7.64 M | $ 193.03 | -4.91 % | $ 19 B | ||
|
Celcuity
CELC
|
54 K | $ 117.14 | -6.02 % | $ 5.48 B | ||
|
Lantheus Holdings
LNTH
|
3.8 M | $ 80.59 | -1.03 % | $ 5.44 B | ||
|
Senseonics Holdings
SENS
|
496 K | $ 6.68 | 0.15 % | $ 279 M | ||
|
Motus GI Holdings
MOTS
|
169 K | - | -34.28 % | $ 263 K | ||
|
Soleno Therapeutics
SLNO
|
726 K | $ 52.63 | 0.23 % | $ 2.67 B | ||
|
Quest Diagnostics Incorporated
DGX
|
174 M | $ 191.51 | -3.19 % | $ 21.3 B | ||
|
Neogen Corporation
NEOG
|
5.64 M | $ 9.42 | -6.13 % | $ 2.04 B | ||
|
ENDRA Life Sciences
NDRA
|
129 K | $ 4.94 | -6.97 % | $ 3.89 M | ||
|
Neuronetics
STIM
|
5.56 M | $ 1.35 | -2.17 % | $ 89 M | ||
|
National Research Corporation
NRC
|
451 K | $ 16.48 | -3.34 % | $ 369 M |